Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 8/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 1.00 |
| ▸ | HPGD | P15428 | 7/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.65 |
| ▸ | HMGB1 | P09429 | 2/20 | 0.61 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.61 |
| ▸ | CA12 | O43570 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.61 |
| ▸ | CA4 | P22748 | 1/20 | 0.61 |
| ▸ | CA6 | P23280 | 1/20 | 0.61 |
| ▸ | CA7 | P43166 | 1/20 | 0.61 |
| ▸ | CA9 | Q16790 | 1/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.61 |
| ▸ | ESR1 | P03372 | 6/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Salsalate SCHEMBL29362887 | 1.00 | HSD17B10 (1.00) | HSD17B10KDM4EHPGDALDH1A1LMNA | |
| Salsalate SCHEMBL2025628 | 1.00 | HSD17B10 (1.00) | HSD17B10KDM4EHPGDALDH1A1LMNA | |
| SCHEMBL13826872 | 0.98 | HSD17B10 (0.96) | HSD17B10KDM4EHPGDALDH1A1LMNA | |
| SCHEMBL3264360 | 0.98 | HSD17B10 (0.96) | HSD17B10KDM4EHPGDALDH1A1LMNA | |
| Salsalate SCHEMBL9624915 | 0.98 | HSD17B10 (0.96) | HSD17B10KDM4EHPGDALDH1A1LMNA | |
| Salsalate SCHEMBL25177171 | 0.98 | KDM4E (0.96) | HSD17B10KDM4EHPGDALDH1A1LMNA | |
| Salsalate SCHEMBL25260636 | 0.98 | HSD17B10 (0.96) | HSD17B10KDM4EHPGDALDH1A1LMNA | |
| Salsalate SCHEMBL12477400 | 0.98 | HSD17B10 (0.96) | HSD17B10KDM4EHPGDALDH1A1LMNA | |
| Salsalate SCHEMBL1802439 | 0.98 | HSD17B10 (0.96) | HSD17B10KDM4EHPGDALDH1A1LMNA | |
| Salsalate SCHEMBL9704557 | 0.98 | HSD17B10 (0.96) | HSD17B10KDM4EHPGDALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 33554 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137702-A1 | Salicylate Compound Composition | INNOVATE EU LTD (GB) | 2026-05-21 | — | — | US | claimed |
| EP-3841097-B1 | 2,6-BIS(((1H-BENZO[D]IMIDAZOL-2-YL)THIO)METHYL)PYRIDINE AND N2,N6-DIBENZYLPYRIDINE-2,6-DICARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITORS FOR TREATING CANCER | BIOMEDICAL RES FOUNDATION OF THE ACADEMY OF ATHENS BRFAA (GR) | 2026-05-20 | — | — | EP | claimed |
| US-20260130928-A1 | COMBINATION OF AKR1C3 ACTIVATED ANTICANCER PRODRUG COMPOUND AND ANALGESIC DRUG FOR TREATING CANCER PATIENTS ACCOMPANIED BY PAIN | ASCENTAWITS PHARMACEUTICALS LTD (CN) | 2026-05-14 | — | — | US | claimed |
| CN-122005693-A | Application of Jiaweidanzhi Xiaoyao powder or extract thereof in preparation of medicines for treating depression complicated with ulcerative colitis | 河南中医药大学 | 2026-05-12 | — | — | CN | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| US-20260115209-A1 | COMBINATION THERAPY INCLUDING COX-2 INHIBITOR FOR THE TREATMENT OF CANCER | UNIV CALIFORNIA (US) | 2026-04-30 | — | — | US | claimed |
| US-12605432-B2 | Combinations for antigen based therapy | DIAMYD MEDICAL AB (SE) | 2026-04-21 | — | — | US | claimed |
| US-20260097044-A1 | ION PAIR LIQUID CRYSTAL FORMULATIONS FOR LONG-ACTING INJECTABLES OF POORLY SOLUBLE DRUGS | FORDOZ PHARMA CORP. (US) | 2026-04-09 | — | — | US | claimed |
| US-20260069532-A1 | METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUE | MEDINCELL S.A. (FR) | 2026-03-12 | — | — | US | claimed |
| US-12558309-B2 | Method for morselizing and/or targeting pharmaceutically active principles to synovial tissue | MEDINCELL S.A. (FR) | 2026-02-24 | — | — | US | claimed |
| US-4341819-A | USING METHYLENEDISALICYLIC AS CURING AGENT | THE POLYMER CORPORATION (US) | 1982-07-27 | — | — | US | claimed |
| EP-0055870-A1 | Pyridylmethyl esters of selected bio-affecting carboxylic acids, process for preparing and pharmaceutical composition comprising the same | MERCK & CO. INC. (US) | 1982-07-14 | — | — | EP | claimed |
| WO-1982002155-A1 | EPOXY COATING POWDERS WITH WRINKLE FINISHES | POLYMER CORP (US) | 1982-07-08 | — | — | WO | claimed |
| EP-0051278-A1 | Soft tertiary amine esters of bio-affecting carboxylic acids, processes for preparing and a pharmaceutical composition containing the same | MERCK & CO. INC. (US) | 1982-05-12 | — | — | EP | claimed |
| EP-0046270-A1 | Novel derivatives of bio-affecting phenolic compounds and pharmaceutical composition containing them | INTERx RESEARCH CORPORATION (US) | 1982-02-24 | — | — | EP | claimed |
| US-4203619-A | HEATING THE COATING CONTAINING A CHROMOGENIC MATERIAL, COOLING AND SETTING; SOLVENT-FREE | THE MEAD CORPORATION (US) | 1980-05-20 | — | — | US | claimed |
| EP-0009046-A1 | COMPOSITION CONTAINING SALICYLSALICYCLIC ACID AND ACETAMINOPHEN | ZOBIAN, Ernest, P., Jr. (US) | 1980-04-02 | — | — | EP | claimed |
| WO-1979000556-A1 | COMPOSITION CONTAINING SALICYLSALICYLIC ACID AND ACETAMINOPHEN | ZOBIAN E | 1979-08-23 | — | — | WO | claimed |
| US-3988509-A | Reduced melt index, low gel content ethylene copolymers and process for preparation thereof | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-10-26 | — | — | US | claimed |
| US-3954533-A | NITROCELLULOSE, NITROGLYCERIN AND BALLISTIC MODIFIERS OF LEAD- AND COPPER- SALTS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1976-05-04 | — | — | US | claimed |